Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response

about

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response

Item

http://www.wikidata.org/entity/Q40529775

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Hepatitis C RNA assay differen ...... f Sustained Virologic Response

@en

type

Item

label

Hepatitis C RNA assay differen ...... f Sustained Virologic Response

@en

prefLabel

Hepatitis C RNA assay differen ...... f Sustained Virologic Response

@en

P1476

Hepatitis C RNA assay differen ...... f Sustained Virologic Response

@en

P2093

Christine Herman

http://www.w3.org/2001/XMLSchema#string

Christoph Sarrazin

http://www.w3.org/2001/XMLSchema#string

Gavin Cloherty

http://www.w3.org/2001/XMLSchema#string

George Dawson

http://www.w3.org/2001/XMLSchema#string

Heiner Wedemeyer

http://www.w3.org/2001/XMLSchema#string

Johannes Vermehren

http://www.w3.org/2001/XMLSchema#string

Jordan J Feld

http://www.w3.org/2001/XMLSchema#string

Stephane Chevaliez

http://www.w3.org/2001/XMLSchema#string

Vera Holzmayer

http://www.w3.org/2001/XMLSchema#string

P2860

Improved COBAS TaqMan Hepatitis C Virus Test (Version 2.0) for Use with the High Pure System: Enhanced Genotype Inclusivity and Performance Characteristics in a Multisite Study

Global epidemiology and genotype distribution of the hepatitis C virus infection

Comparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5

Performance of the Abbott Real-Time PCR Assay Using m2000sp and m2000rt for Hepatitis C Virus RNA Quantification

Evaluation of the Abbott Investigational Use Only RealTime Hepatitis C Virus (HCV) Assay and Comparison to the Roche TaqMan HCV Analyte-Specific Reagent Assay

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis.

Global burden of disease (GBD) for hepatitis C.

P2888

srep35410

P304

35410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP35410

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Michel Pawlotsky

Benjamin Maasoumy

P577

2016-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27762283

http://www.w3.org/2001/XMLSchema#string

P921

virology

P932

5071881

http://www.w3.org/2001/XMLSchema#string